ERELZI
LIVE

Serial Number

79411104

Owner

Sandoz AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ERELZI Trademark

Serial Number: 79411104 • Registration: 7998523

ERELZI is a trademark filed by Sandoz AG on October 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sandoz AG (8 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

October 15, 2024

Registration Date

October 28, 2025

Published for Opposition

September 9, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 28, 2026 FINV
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 14, 2026 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 10, 2026 FICS
FINAL DISPOSITION PROCESSED
May 10, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 27, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 28, 2026 FICR
INTERNATIONAL REGISTRATION RENEWED
Nov 20, 2025 RNWL
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 4, 2024 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 28, 2024 SDRC